Phase 2 Trial of Avelumab in Combination with Gemcitabine in Advanced Leiomyosarcoma As a Second-Line Treatment (EAGLES, Korean Cancer Study Group UN18-09)
CANCER（2024）
关键词
avelumab,gemcitabine,leiomyosarcoma,survival,tumor-infiltrating lymphocytes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要